PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic Framework with Effective Nanozyme Performance and Cuproptosis Induction Efficacy for Enhanced PD-L1-based Immunotherapy DOI Creative Commons
Xufeng Lu,

Wenhai Deng,

Shuaibin Wang

et al.

Materials Today Bio, Journal Year: 2024, Volume and Issue: 29, P. 101317 - 101317

Published: Oct. 30, 2024

Language: Английский

HMGB1 in the interplay between autophagy and apoptosis in cancer DOI
Ruochan Chen,

Zou Ju,

Xiao Yan Zhong

et al.

Cancer Letters, Journal Year: 2023, Volume and Issue: 581, P. 216494 - 216494

Published: Nov. 24, 2023

Language: Английский

Citations

26

Targeting paraptosis in cancer: opportunities and challenges DOI Open Access
Fangquan Chen, Hu Tang,

Xiutao Cai

et al.

Cancer Gene Therapy, Journal Year: 2024, Volume and Issue: 31(3), P. 349 - 363

Published: Jan. 4, 2024

Language: Английский

Citations

13

Emerging role of immunogenic cell death in cancer immunotherapy DOI Creative Commons

Kei‐ichiro Arimoto,

Sayuri Miyauchi,

Mengdan Liu

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: May 10, 2024

Cancer immunotherapy, such as immune checkpoint blockade (ICB), has emerged a groundbreaking approach for effective cancer treatment. Despite its considerable potential, clinical studies have indicated that the current response rate to immunotherapy is suboptimal, primarily attributed low immunogenicity in certain types of malignant tumors. Immunogenic cell death (ICD) represents form regulated (RCD) capable enhancing tumor and activating tumor-specific innate adaptive responses immunocompetent hosts. Therefore, gaining deeper understanding ICD evolution crucial developing more therapeutic strategies. This review focuses exclusively on both historical recent discoveries related modes their mechanistic insights, particularly within context immunotherapy. Our findings are also highlighted, revealing mode induction facilitated by atypical interferon (IFN)-stimulated genes (ISGs), including polo-like kinase 2 ( PLK2 ), during hyperactive type I IFN signaling. The concludes discussing potential ICD, with special attention relevance preclinical settings field

Language: Английский

Citations

13

AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer DOI Creative Commons
Zicheng Sun,

Hua‐Zhen Xu,

Guan-Ming Lu

et al.

Advanced Science, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 20, 2025

Abstract Cuproptosis, a recently defined copper‐dependent cell death pathway, remains largely unexplored in tumor therapies, particularly breast cancer. This study demonstrates that triple‐negative cancer (TNBC) bears relatively elevated copper levels and exhibits resistance to cuproptosis. Mechanistically, activates the AKT signaling which inhibits ferredoxin‐1 (FDX1), key regulator of AKT1‐mediated FDX1 phosphorylation not only abrogates FDX1‐induced cuproptosis aerobic respiration but also promotes glycolysis. Consequently, combination AKT1 inhibitors ionophores synergistically alleviate TNBC tumorigenesis both vitro vivo. In summary, findings reveal crucial mechanism underlying suggest potential therapeutic approach for TNBC.

Language: Английский

Citations

1

Dying to survive: harnessing inflammatory cell death for better immunotherapy DOI
Long Cheng, Yibo Wang, Ying Zhang

et al.

Trends in cancer, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

1

Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials DOI

Zixin Wu,

Guishuai Lv,

Fuxue Xing

et al.

Cancer Letters, Journal Year: 2023, Volume and Issue: 571, P. 216348 - 216348

Published: Aug. 9, 2023

Language: Английский

Citations

20

Cuproptosis: emerging biomarkers and potential therapeutics in cancers DOI Creative Commons
Min Wang, Lianwen Zheng, Shuai Ma

et al.

Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13

Published: Nov. 7, 2023

The sustenance of human life activities depends on copper, which also serves as a crucial factor for vital enzymes. Under typical circumstances, active homeostatic mechanisms keep the intracellular copper ion concentration low. Excess ions cause excessive cellular respiration, causes cytotoxicity and cell death levels steadily rise above threshold. It is novel that mitochondrial ions, regulation. Cuproptosis now understood to play role in several pathogenic processes, including inflammation, oxidative stress, apoptosis. Copper type regulatory death(RCD).Numerous diseases are correlated with development homeostasis imbalances. One most popular areas study field cancer cuproptosis. has been discovered angiogenesis, proliferation, growth, metastasis all accumulation ions. concentrations can serve marker development. In order reference clinical research product, diagnosis, treatment cancer, this paper covers function imbalance malignant cancers related molecular pathways.

Language: Английский

Citations

19

The redox protein HMGB1 in cell death and cancer DOI
Ruochan Chen, Ju Zou, Rui Kang

et al.

Antioxidants and Redox Signaling, Journal Year: 2023, Volume and Issue: unknown

Published: Feb. 2, 2023

Significance: As a redox-sensitive protein, high-mobility group box 1 (HMGB1) is implicated in regulating stress responses to oxidative damage and cell death, which are closely related the pathology of inflammatory diseases, including cancer. Recent advances: HMGB1 non-histone nuclear protein that acts as DNA chaperone control chromosomal structure function. can also be released into extracellular space function damage-associated molecular pattern during apoptosis, necrosis, necroptosis, pyroptosis, ferroptosis, alkaliptosis, cuproptosis. Once released, binds membrane receptors shape immune metabolic responses. In addition subcellular localization, activity depends on its redox state posttranslational modifications. Abnormal plays dual role tumorigenesis anticancer therapy (e.g., chemotherapy, radiation therapy, immunotherapy) depending tumor types stages. Critical issues: A comprehensive understanding cellular homeostasis important for deciphering normal functions pathological manifestations. this review, we discuss compartmental-defined roles death Understanding these advances may help us develop potential HMGB1-targeting drugs or approaches treat stress-related diseases conditions. Future directions: Further studies required dissect mechanism by maintains under different multidisciplinary effort evaluate applications precisely targeting pathway human health disease.

Language: Английский

Citations

17

Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies DOI Creative Commons

Haohui Fan,

Kun Wang,

Xiaofang Zhao

et al.

Frontiers in Aging Neuroscience, Journal Year: 2024, Volume and Issue: 16

Published: April 23, 2024

The expanding geriatric population, whose predisposition toward disabling morbidities and age-related diseases (ARD) is well-documented, has become a paramount social issue, exerting an onerous burden on both the healthcare industry wider society. ARD manifest as progressive deterioration of bodily tissues organs, eventually resulting in failure these vital components. At present, no efficacious measures exist to hinder onset ARD. Copper, essential trace element, involved wide range physiological processes across different cell types. In recent research, novel variant copper-dependent death, termed cuproptosis, been identified. This mode cellular demise stands apart from previously recognized types death. Cuproptosis occurs when copper binds with acyl-CoA synthetase tricarboxylic acid (TCA) cycle, protein aggregation toxicity stress, ultimately leading this paper, we provide concise overview current understanding concerning metabolism copper, copper-related diseases, hallmarks toxicity, mechanisms that regulate toxicity. Additionally, discuss implications cuproptosis mutations development ARD, well potential for targeting treatment

Language: Английский

Citations

8

DAMPs in immunosenescence and cancer DOI Creative Commons
Fangquan Chen, Hu Tang,

Xiutao Cai

et al.

Seminars in Cancer Biology, Journal Year: 2024, Volume and Issue: 106-107, P. 123 - 142

Published: Sept. 30, 2024

Language: Английский

Citations

7